These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21127417)

  • 1. Resveratrol protects against a model of vacuous chewing movements induced by reserpine in mice.
    Busanello A; Barbosa NB; Peroza LR; Farias LE; Burger ME; Barreto KP; Fachinetto R
    Behav Pharmacol; 2011 Feb; 22(1):71-5. PubMed ID: 21127417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol reduces vacuous chewing movements induced by acute treatment with fluphenazine.
    Busanello A; Peroza LR; Wagner C; Sudati JH; Pereira RP; Prestes Ade S; Rocha JB; Fachinetto R; Barbosa NB
    Pharmacol Biochem Behav; 2012 Apr; 101(2):307-10. PubMed ID: 22266770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.
    Busanello A; Leal CQ; Peroza LR; Röpke J; de Moraes Reis E; de Freitas CM; Libardoni M; de Vargas Barbosa NB; Fachinetto R
    Neurochem Res; 2017 Nov; 42(11):3033-3040. PubMed ID: 28744755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of baclofen on reserpine-induced vacuous chewing movements in mice.
    Castro JP; Frussa-Filho R; Fukushiro DF; Silva RH; Medrano WA; Ribeiro Rde A; Abílio VC
    Brain Res Bull; 2006 Feb; 68(6):436-41. PubMed ID: 16459199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallic acid decreases vacuous chewing movements induced by reserpine in rats.
    Reckziegel P; Peroza LR; Schaffer LF; Ferrari MC; de Freitas CM; Bürger ME; Fachinetto R
    Pharmacol Biochem Behav; 2013 Mar; 104():132-7. PubMed ID: 23313549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats.
    Pereira RP; Fachinetto R; de Souza Prestes A; Wagner C; Sudati JH; Boligon AA; Athayde ML; Morsch VM; Rocha JB
    J Neural Transm (Vienna); 2011 Nov; 118(11):1547-57. PubMed ID: 21476069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide.
    Burger M; Fachinetto R; Calegari L; Paixão MW; Braga AL; Rocha JB
    Brain Res Bull; 2004 Dec; 64(4):339-45. PubMed ID: 15561469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CATECHIN on reserpine-induced vacuous chewing movements: behavioral and biochemical analysis.
    Reinheimer JB; Bressan GN; de Freitas CM; Ceretta APC; Krum BN; Nogara PA; Rodrigues T; Schwerz JP; da Rocha JBT; Fachinetto R
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2439-2452. PubMed ID: 32725283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
    Naidu PS; Singh A; Kulkarni SK
    Pharmacology; 2004 Feb; 70(2):59-67. PubMed ID: 14685008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of nebivolol on reserpine-induced neurobehavioral and biochemical alterations in rats.
    Nade VS; Shendye NV; Kawale LA; Patil NR; Khatri ML
    Neurochem Int; 2013 Oct; 63(4):316-21. PubMed ID: 23871717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and neurochemical effects induced by reserpine in mice.
    de Freitas CM; Busanello A; Schaffer LF; Peroza LR; Krum BN; Leal CQ; Ceretta AP; da Rocha JB; Fachinetto R
    Psychopharmacology (Berl); 2016 Feb; 233(3):457-67. PubMed ID: 26514557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter.
    Fachinetto R; Villarinho JG; Wagner C; Pereira RP; Avila DS; Burger ME; Calixto JB; Rocha JB; Ferreira J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1478-86. PubMed ID: 17669571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia.
    Shoham S; Mazeh H; Javitt DC; Heresco-Levy U
    Brain Res; 2004 Apr; 1004(1-2):142-7. PubMed ID: 15033429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topiramate on oral dyskinesia induced by reserpine.
    Araujo NP; Abílio VC; Silva RH; Pereira RC; Carvalho RC; Gonzalez C; Bellot RG; Castro JP; Fukushiro DF; Rodrigues MS; Chinen CC; Frussa-Filho R
    Brain Res Bull; 2004 Dec; 64(4):331-7. PubMed ID: 15561468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of MK-801 on reserpine-treated mice.
    Dutra RC; Andreazza AP; Andreatini R; Tufik S; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):487-95. PubMed ID: 11999899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Hypericum perforatum on different models of movement disorders in rats.
    Reis EM; Röpke J; Busanello A; Reckziegel P; Leal CQ; Wagner C; Boligon AA; Athayde ML; Fachinetto R
    Behav Pharmacol; 2013 Oct; 24(7):623-7. PubMed ID: 23962987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors.
    Raghavendra V; Naidu PS; Kulkarni SK
    Brain Res; 2001 Jun; 904(1):149-52. PubMed ID: 11516422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice.
    Silva RH; Abílio VC; Torres-Leite D; Bergamo M; Chinen CC; Claro FT; Carvalho Rde C; Frussa-Filho R
    Behav Brain Res; 2002 May; 132(2):171-7. PubMed ID: 11997147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
    Turrone P; Remington G; Kapur S; Nobrega JN
    Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.